1.Deep Vein Thrombosis in the Lower Extremities in Comatose Elderly Patients with Acute Neurological Diseases.
Shoko Merrit YAMADA ; Yusuke TOMITA ; Hideki MURAKAMI ; Makoto NAKANE
Yonsei Medical Journal 2016;57(2):388-392
PURPOSE: Comatose elderly patients with acute neurological illness have a great risk of deep vein thrombosis (DVT). In this study, the incidence of DVT and the effectiveness of early initiation of treatment were evaluated in those patients. MATERIALS AND METHODS: Total 323 patients were admitted to our ward due to neurological diseases in one year, and 43 patients, whose Glasgow Coma Scale was < or =11 and who was older than > or =60 years, were included in this study. D-dimer was measured on admission and day 7, and lower-extremity ultrasonography was performed on day 7. When DVT was positive, heparin treatment was initiated, and further evaluation of pulmonary embolism (PE) was conducted. Vena cava filter protection was inserted in PE-positive patients. Incidence of DVT and PE, alteration of D-dimer value, and effect of heparin treatment were analyzed. RESULTS: DVT was positive in 19 (44.2%) patients, and PE was in 4 (9.3%). D-dimer was significantly higher in DVT-positive group on day 7 (p<0.01). No DVT were identified in patients with ischemic disease, while 66.7% of intracerebral hemorrhage and 53.3% of brain contusion patients were DVT positive. Surgery was a definite risk factor for DVT, with an odds ratio of 5.25. DVT and PE disappeared by treatment in all cases, and no patients were succumbed to the thrombosis. CONCLUSION: Patients with hemorrhagic diseases or who undergo operation possess high risk of DVT, and initiation of heparin treatment in 7 days after admission is an effective prophylaxis for DVT in comatose elderly patients without causing bleeding.
Acute Disease
;
Aged
;
Anticoagulants/adverse effects/therapeutic use
;
Antifibrinolytic Agents/therapeutic use
;
*Coma
;
Female
;
Fibrin Fibrinogen Degradation Products/therapeutic use
;
Hemorrhage/*epidemiology
;
Heparin/adverse effects/therapeutic use
;
Humans
;
Incidence
;
Japan/epidemiology
;
Lower Extremity
;
Male
;
Middle Aged
;
Nervous System Diseases/epidemiology
;
Neurosurgical Procedures/*adverse effects
;
Pulmonary Embolism/*complications/epidemiology/prevention & control
;
Risk Factors
;
Venous Thrombosis/epidemiology/*etiology/prevention & control
2.Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients.
Woo Lam JO ; Young Kyun LEE ; Yong Chan HA ; Kyung Min LEE ; Bun Jung KANG ; Kyung Hoi KOO
Journal of Korean Medical Science 2016;31(8):1319-1323
Intermittent Pneumatic Compression (IPC) device has been used to prevent venous thromboembolism (VTE). This study investigated the effectiveness of IPC device. We evaluated incidences of deep vein thrombosis (DVT) and pulmonary embolism (PE) in total hip arthroplasty (THA) patients after use of IPC device, and compared with historical incidences from our institution. We applied IPC device in 741 patients who underwent 870 elective primary THAs from January 2010 to December 2013, DVT was detected in 3 patients (0.3%) by sonography, and one (0.1%) of them was symptomatic. Symptomatic PE occurred in 1 patient (0.1%) and there were no cases of fatal PE. The incidence of symptomatic DVT was significantly lower than the historical control (P = 0.042). The IPC is a safe and effective prophylaxis of VTE after primary THA in Korea.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Arthroplasty, Replacement, Hip/*adverse effects
;
Humans
;
Incidence
;
*Intermittent Pneumatic Compression Devices
;
Middle Aged
;
Postoperative Complications/etiology
;
Pulmonary Embolism/diagnostic imaging/epidemiology/*prevention & control
;
Republic of Korea/epidemiology
;
Risk Factors
;
Ultrasonography
;
Venous Thromboembolism/diagnostic imaging/epidemiology/*prevention & control
;
Young Adult
3.Preventing Venous Thromboembolism with Use of Intermittent Pneumatic Compression after Total Hip Arthroplasty in Korean Patients.
Woo Lam JO ; Young Kyun LEE ; Yong Chan HA ; Kyung Min LEE ; Bun Jung KANG ; Kyung Hoi KOO
Journal of Korean Medical Science 2016;31(8):1319-1323
Intermittent Pneumatic Compression (IPC) device has been used to prevent venous thromboembolism (VTE). This study investigated the effectiveness of IPC device. We evaluated incidences of deep vein thrombosis (DVT) and pulmonary embolism (PE) in total hip arthroplasty (THA) patients after use of IPC device, and compared with historical incidences from our institution. We applied IPC device in 741 patients who underwent 870 elective primary THAs from January 2010 to December 2013, DVT was detected in 3 patients (0.3%) by sonography, and one (0.1%) of them was symptomatic. Symptomatic PE occurred in 1 patient (0.1%) and there were no cases of fatal PE. The incidence of symptomatic DVT was significantly lower than the historical control (P = 0.042). The IPC is a safe and effective prophylaxis of VTE after primary THA in Korea.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Arthroplasty, Replacement, Hip/*adverse effects
;
Humans
;
Incidence
;
*Intermittent Pneumatic Compression Devices
;
Middle Aged
;
Postoperative Complications/etiology
;
Pulmonary Embolism/diagnostic imaging/epidemiology/*prevention & control
;
Republic of Korea/epidemiology
;
Risk Factors
;
Ultrasonography
;
Venous Thromboembolism/diagnostic imaging/epidemiology/*prevention & control
;
Young Adult
4.Prophylaxis against venous thromboembolism in orthopedic surgery.
Chinese Journal of Traumatology 2006;9(4):249-256
Venous thromboembolism (VTE), which is manifested as deep vein thrombosis (DVT) and pulmonary embolism (PE), represents a significant cause of death, disability, and discomfort. They are frequent complications of various surgical procedures. The aging population and the survival of more severely injured patients may suggest an increasing risk of thromboembolism in the trauma patients. Expanded understanding of the population at risk challenges physicians to carefully examine risk factors for VTE to identify high-risk patients who can benefit from prophylaxis. An accurate knowledge of evidence-based risk factors is important in predicting and preventing postoperative DVT, and can be incorporated into a decision support system for appropriate thromboprophylaxis use. Standard use of DVT prophylaxis in a high-risk trauma population leads to a low incidence of DVT. The incidence of VTE is common in Asia. The evaluation includes laboratory tests, Doppler test and phlebography. Screening Doppler sonography should be performed for surveillance on all critically injured patients to identify DVT. D-Dimer is a useful marker to monitor prophylaxis in trauma surgery patients. The optimal time to start prophylaxis is between 2 hours before and 10 hours after surgery, but the risk of PE continues for several weeks. Thromboprophylaxis includes graduated compression stockings and anticoagulants for prophylaxis. Anticoagulants include Warfarin, which belongs to Vitamin K antagonists, unfractionated heparin, low molecular weight heparins, factor Xa indirect inhibitor Fondaparinux, and the oral IIa inhibitor Melagatran and ximelagatran. Recombinant human soluble thrombomodulin is a new and highly effective antithrombotic agent. Prophylactic placement of vena caval filters in selected trauma patients may decrease the incidence of PE. The indications for prophylactic inferior vena cava filter insertion include prolonged immobilization with multiple injuries, closed head injury, pelvic fracture, spine fracture, multiple long bone fracture, and attending discretion. Multiple-trauma patients are at increased risk for DVT but are also at increased risk of bleeding, and the use of heparin may be contraindicated. Serial compression devices (SCDs) are an alternative for DVT prophylaxis. Compression devices provide adequate DVT prophylaxis with a low failure rate and no device-related complications. Immobilization is one of important reasons of VTE. The ambulant patient is far less likely to develop complications of inactivity, not only venous thrombosis, but also contractures, decubitus ulcers, or osteoporosis (with its associated fatigue fractures), as well as bowel or bladder complications.
Anticoagulants
;
therapeutic use
;
Factor Xa Inhibitors
;
Heparin
;
therapeutic use
;
Heparin, Low-Molecular-Weight
;
therapeutic use
;
Humans
;
Orthopedic Procedures
;
adverse effects
;
Postoperative Complications
;
epidemiology
;
Pulmonary Embolism
;
prevention & control
;
Recombinant Proteins
;
therapeutic use
;
Risk Factors
;
Thrombomodulin
;
therapeutic use
;
Vena Cava Filters
;
Venous Thrombosis
;
epidemiology
;
prevention & control
;
Vitamin K
;
antagonists & inhibitors
;
Warfarin
;
therapeutic use